Archives: Speakers

Gunilla Andrew-Nielsen has held her current position as Head of Clinical Trial and Special Permission at the MPA in Sweden during seven years. Since the early 1990s, she has held various positions within global R&D in the pharma industry including project and training management and later as Director of Quality Assurance.

Arnaud Dourlens is an Arts et Métiers engineer, he began his industrial career in the FMCG sector where he held growing responsibilities. Then he joined the LVMH group where he reorganized new product launches and industrial investments in the Make-up segment in order to adapt to the need for innovation and time to market, thus providing a competitive advantage. He then managed the entire portfolio of industrial launches and investments in Perfumes, Skincare and Make-up for Parfums Christian Dior Group.

During his career Arnaud held a wide variety of industrial roles. He joined Sanofi in 2017 as Production Director of a major solid oral form production site (>2.5 billion € turnover). He has been a key player in the development of the continuous improvement mindset and in the transformation of the site through IT projects, investments and activity growth following the acquisition of Boehringer Ingelheim consumer healthcare portfolio.

Since the beginning of 2020, he’s been the global head of Sanofi Clinical Supply Chain Operations, managing worldwide clinical supply teams involved in more than 300 clinical studies.

With a keen eye for Strategic Vision, Jonathan has been at the forefront of advancing analytical capabilities, particularly in site intelligence, operational metrics, and quality indicators. With a prowess in Digital Transformation has been instrumental in the on-time delivery and precision of a diverse suite of predictive models, leveraging ML/AI and Generative AI technologies.

Tine Bülow is an established Supply Chain Project Manager with over 12 years of experience in clinical IT systems. She brings extensive expertise in integrating clinical technologies to optimize trial operations, with a strong focus on temperature management and data integrity throughout the temperature deviation process. Her background includes 8 years working with Interactive Response Technology (IRT) systems and 4 years dedicated to advanced temperature control solutions.

Tine’s work centers on safeguarding both product and data integrity across the entire supply chain—from packaging and shipment to storage at clinical sites—ensuring that patients receive safe and effective investigational products under optimal conditions. Passionate about reliability and compliance, she is committed to driving smarter, innovative solutions that strengthen quality, trustworthiness, and integrity in clinical trial delivery—ultimately protecting patient safety and improving trial outcomes.

Helén Johansen Blanco has 24 years of clinical development experience, managing Phase I to III clinical trials leading to the successful launch of several oncology products, as Revlimid, Xofigo and a Herceptin biosimilar. She has experience in project management and financial oversight of large global clinical trials conducted in all continents of the world, mainly within oncology, but also therapeutic areas as cardiovascular and gastrointestinal. Mrs. Blanco has previously worked for large international pharma companies such as AstraZeneca and Mylan, as well as small, medium to large sized biotechnology companies as Nordic Nanovector, Oncoinvent, Cantargia, Cytovation and Celgene. Currently she holds a position as Chief Operating Officer at Node Pharma AS, a small medium sized Norwegian biotech company. She holds a Diploma Engineer/MSc degree in Biophysics and medical technology and a MBA.

Dr. Alexander Debets has more than 30 years of experience in analytical and pharmaceutical R&D.

He previously worked for Organon and Schering-Plough. He held several roles of increasing responsibility in Analytical Development, Pharmaceutical Development and Clinical Supply Operations in the Netherlands. He was site head of development manufacturing sites in Germany and in Switzerland, which involved the transition of a site from research and development into commercial. He did lead the Global Clinical Supply organization at MSD in the US.

Recently he held a position of Lead Clinical Supply Innovation, driving new opportunities to enhance the clinical supply chain for patients, sites and sponsor.

His educational background includes a Doctor in Chemistry, and a Master’s Degree in Analytical🥾 Chemistry and Toxicology from the Free University, Amsterdam, the Netherlands.

He was chairman of several committees and councils, including global harmonization steering committees for Analytical Chemistry, Manufacturing and Control (CMC) processes, Quality and international Procurement Improvements. He was board-member of the Analytical Section of the Royal Dutch Chemical Society and president of the Analytical Lab Managers Association.